Forigerimod (IPP-201101) is a CD4 T-cell modulator. Forigerimod is a 21-amino-acid fragment.
CAT No: R2020
CAS No:497156-60-2
Synonyms/Alias:Forigerimod (USAN/INN);497156-60-2;D09904;
Forigerimod is a synthetic peptide compound that has garnered significant attention in immunological and biochemical research due to its unique sequence and functional properties. As a linear peptide, Forigerimod is characterized by its ability to interact with major histocompatibility complex (MHC) molecules, making it a valuable tool for studies focused on antigen presentation and T-cell modulation. Its design and sequence specificity have enabled researchers to probe fundamental aspects of immune system signaling, peptide-MHC interactions, and the fine-tuning of immune responses. The compound's robust stability and defined structure further underpin its utility in a range of experimental systems, positioning it as a versatile reagent for advanced peptide research and immunological investigations.
Immunological research: Forigerimod serves as a model antigenic peptide for dissecting the molecular mechanisms of T-cell receptor (TCR) recognition and activation. Its defined sequence allows for precise evaluation of peptide-MHC complex formation and the downstream signaling cascades that drive T-cell responses. Researchers utilize this peptide to elucidate the specificity and sensitivity of TCR engagement, enabling a deeper understanding of immune tolerance, activation thresholds, and the determinants of immunodominance. Such studies are essential for mapping antigenic landscapes and for the rational design of immunomodulatory agents.
Autoimmunity modeling: The application of Forigerimod in experimental models of autoimmunity provides critical insights into the processes underlying self-tolerance and aberrant immune activation. By introducing this peptide into cellular or animal systems, investigators can simulate and monitor the breakdown of tolerance mechanisms, investigate the role of specific T-cell subsets, and assess the impact of peptide presentation on disease-relevant immune responses. These studies contribute to the broader field of autoimmune disease research, offering a controlled means of probing the molecular underpinnings of self-reactivity.
Peptide-MHC binding assays: Forigerimod is frequently employed in quantitative and qualitative assays designed to assess peptide binding affinity to various MHC class II molecules. Its well-characterized sequence and binding profile make it an ideal standard or reference peptide in competitive binding experiments, stability studies, and structural analyses. Such assays are fundamental for characterizing the peptide-binding repertoire of MHC molecules, optimizing antigen selection, and validating computational predictions of peptide-MHC interactions in both basic and applied research settings.
Epitope mapping: The defined structure of Forigerimod enables its use in systematic epitope mapping protocols aimed at identifying T-cell epitopes and characterizing the immunogenic regions of proteins. By incorporating this peptide into scanning or substitution studies, researchers can delineate the critical amino acid residues required for MHC binding and TCR recognition. These insights are invaluable for vaccine design, immunogenicity assessments, and the development of peptide-based immunotherapies, where precise epitope identification is paramount.
Peptide synthesis and analytical validation: In addition to its functional applications, Forigerimod is utilized as a reference standard in peptide synthesis workflows and analytical method development. Its stability and sequence-specific properties facilitate the calibration of chromatographic systems, mass spectrometry protocols, and purity assessments. Analytical laboratories benefit from using such well-characterized peptides to validate synthesis yields, verify structural integrity, and benchmark analytical performance, thereby ensuring reproducibility and accuracy in peptide-focused research and development environments.
2. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More